TECTONIC THERAPEUTIC, INC. Stock-Based Compensation
TECTONIC THERAPEUTIC, INC. (TECX) reported Stock-Based Compensation of $7.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.01M, a 55.02% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.21M, a 52.40% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.99M, a 167.59% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.82M, a 70.73% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $10.50M, a 200.69% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $3.49M, a 211.42% increase from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $1.12M, a 90.27% decline from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $11.52M, a 37.98% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.22M 10-Q · filed 2026-08-06 | $10.21M derived: sum of 3 quarters · filed 2026-08-06 | $13.02M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $3.21M 10-Q · filed 2026-05-07 | $6.19M derived: sum of 2 quarters · filed 2026-05-07 | $9.01M derived: sum of 3 quarters · filed 2026-05-07 | $11.60M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.81M derived: sum of 2 quarters · filed 2026-02-26 | $8.39M derived: sum of 3 quarters · filed 2026-08-06 | $10.50M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.41M derived: sum of 2 quarters · filed 2026-08-06 | $7.51M 10-Q · filed 2025-11-06 | $8.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.69M 10-Q · filed 2026-08-06 | $5.81M derived: sum of 3 quarters · filed 2026-08-06 | $7.46M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.10M 10-Q · filed 2026-05-07 | $3.22M derived: sum of 2 quarters · filed 2026-05-07 | $4.87M derived: sum of 3 quarters · filed 2026-05-07 | $5.27M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.77M derived: sum of 2 quarters · filed 2026-02-26 | $3.17M derived: sum of 3 quarters · filed 2026-02-26 | $3.49M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.05M derived: sum of 2 quarters · filed 2025-11-06 | $2.37M 10-Q · filed 2025-11-06 | $2.67M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $403.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $724.00K 10-Q · filed 2025-08-07 | $1.02M derived: sum of 3 quarters · filed 2025-08-07 | $1.29M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $321.00K 10-Q · filed 2025-05-08 | $878.00K 10-Q · filed 2024-05-09 | $615.00K derived: sum of 2 quarters · filed 2025-05-08 | $890.00K derived: sum of 3 quarters · filed 2025-05-08 | -$1.09M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $569.00K derived: sum of 2 quarters · filed 2025-03-20 | -$1.41M derived: sum of 3 quarters · filed 2025-03-20 | $1.12M 10-K · filed 2025-03-20 | $6.89M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | $275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.70M derived: sum of 2 quarters · filed 2024-11-12 | $827.00K 10-Q · filed 2024-11-12 | $6.28M 10-Q · filed 2023-11-09 | $3.08M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $552.00K 10-Q · filed 2024-08-14 | $4.06M 10-Q · filed 2023-08-10 | $2.81M derived: sum of 3 quarters · filed 2024-08-14 | $5.46M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $2.53M 10-Q · filed 2024-05-09 | $4.79M derived: sum of 2 quarters · filed 2024-05-09 | $7.44M derived: sum of 3 quarters · filed 2024-05-09 | $10.67M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $4.91M derived: sum of 2 quarters · filed 2024-03-14 | $8.14M derived: sum of 3 quarters · filed 2024-03-14 | $11.52M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.89M derived: sum of 2 quarters · filed 2023-11-09 | $9.27M 10-Q · filed 2023-11-09 | $13.35M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $6.61M 10-Q · filed 2023-08-10 | $10.70M derived: sum of 3 quarters · filed 2023-08-10 | $15.86M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $3.38M 10-Q · filed 2023-05-11 | $7.46M derived: sum of 2 quarters · filed 2023-05-11 | $12.63M derived: sum of 3 quarters · filed 2023-05-11 | $17.32M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $9.25M derived: sum of 2 quarters · filed 2023-03-23 | $13.94M derived: sum of 3 quarters · filed 2023-03-23 | $18.58M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $5.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $9.86M derived: sum of 2 quarters · filed 2022-11-08 | $14.49M 10-Q · filed 2022-11-08 | $18.60M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $9.33M 10-Q · filed 2022-08-09 | $13.43M derived: sum of 3 quarters · filed 2022-08-09 | $18.23M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $4.63M 10-Q · filed 2022-05-10 | $8.74M derived: sum of 2 quarters · filed 2022-05-10 | $13.54M derived: sum of 3 quarters · filed 2022-05-10 | $17.44M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $8.91M derived: sum of 2 quarters · filed 2022-03-17 | $12.81M derived: sum of 3 quarters · filed 2022-03-17 | $15.63M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $8.70M derived: sum of 2 quarters · filed 2021-11-04 | $11.53M 10-Q · filed 2021-11-04 | $13.41M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $6.72M 10-Q · filed 2021-08-05 | $8.61M derived: sum of 3 quarters · filed 2021-08-05 | $10.40M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $2.82M 10-Q · filed 2021-05-13 | $4.71M derived: sum of 2 quarters · filed 2021-05-13 | $6.50M derived: sum of 3 quarters · filed 2021-05-13 | $8.17M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $3.68M derived: sum of 2 quarters · filed 2021-03-18 | $5.34M derived: sum of 3 quarters · filed 2021-03-18 | $6.80M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.46M derived: sum of 2 quarters · filed 2020-11-05 | $4.92M 10-Q · filed 2020-11-05 | $5.99M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.12M 10-Q · filed 2020-08-06 | $4.20M derived: sum of 3 quarters · filed 2020-08-06 | $4.75M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $1.46M 10-Q · filed 2020-05-07 | $2.53M derived: sum of 2 quarters · filed 2020-05-07 | $3.08M derived: sum of 3 quarters · filed 2020-05-07 | $3.54M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.63M derived: sum of 2 quarters · filed 2020-03-16 | $2.09M derived: sum of 3 quarters · filed 2020-03-16 | $2.20M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $551.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.01M derived: sum of 2 quarters · filed 2019-11-07 | $1.12M 10-Q · filed 2019-11-07 | $1.18M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $566.00K 10-Q · filed 2019-08-08 | $633.00K derived: sum of 3 quarters · filed 2019-08-08 | $679.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $109.00K 10-Q · filed 2019-05-13 | $176.00K derived: sum of 2 quarters · filed 2019-05-13 | $222.00K derived: sum of 3 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $113.00K derived: sum of 2 quarters · filed 2019-03-25 | $177.00K 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $110.00K 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | $64.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |